Veltassa is a medicine used for treating adults and adolescents aged 12 years and above with high levels of potassium in the blood (hyperkalaemia). Hyperkalaemia can cause serious heart problems and muscle weakness. Veltassa contains the active substance patiromer.
Therapeutic Indication
### Therapeutic indication Veltassa is indicated for the treatment of hyperkalaemia in adults and adolescents aged 12 to 17 years.
Therapeutic Area (MeSH)
ATC Code
V03AE09
ATC Item
patiromer calcium
Pharmacotherapeutic Group
Drugs for treatment of hyperkalemia and hyperphosphatemia
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| patiromer sorbitex calcium | N/A | Patiromer |
EMA Name
Veltassa
Medicine Name
Veltassa
Aliases
N/A
